I want to thank you for including robust funding for maternal and reproductive health in the Department's budget, including doubling funding for title X family planning to $512 million.

It is absolutely essential to a woman's capacity for self-determination and dignity.

prevent unusually large funding changes from year to year in these grants.

$2 billion for State opioid response grants.

I think it should include, not just national security issues, but also economic and democracy support for what is happening in the region.

By simply telling a generic drug manufacturer what adjustments they need to make, our bipartisan bill would help improve the generic market approval process and lower drug prices overall.

This manufacturing monopoly is one of the root causes of the drug shortage, and relying on China for active ingredients is a national security and public health risk.

I appreciate that hospitals and private manufacturers may want to use this data, but I also think it is really essential that the FDA and the United States government use this data too.

Thank you very much, Mr. Chair and Ranking Member Paul, for holding this hearing.

I certainly agree, and I hope we will continue to stay focused on other areas where--on individuals where sanctions can help make a difference.

It is an area that is ripe for interference by both the Russians and the Chinese.

I hope that that is a review that also considers the implication on Afghan women and girls.

If this Administration comes out with an Executive Order that includes all the reforms we are talking about today in June, that will greatly diminish the need for legislation.

Why are we cutting a successful program that provides such important assistance to our small businesses at a time where they need it more than ever?

I am disappointed by some backsliding in the government, but where the people are very clearly committed to looking towards Europe.

Despite the Biden-Harris Administration's prioritization of the repeal of the Global Gag Rule shortly after taking office, I remained concerned by reports over the last 2 years that some implementing partners are still restricting the…

The fact remains that hiking prices and requiring families to fill out forms will likely decrease vaccine uptake and set back the public health effort to combat COVID-19.

This program cannot simply be a public relations exercise that provides cover for the company to hike prices on families seeking COVID-19 vaccines.